| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892 [R. B. H., W-Y. H.]; Clinical Services Program, Science Applications International Corporation-Frederick, Inc., Frederick, Maryland 21702 [C. O. S., W. C. K.]; and American Type Culture Collection, Manassas, Virginia 20110 [Y. R.]
Standardized and cost-effective biological sample collection, processing, and storage procedures are needed in large-scale epidemiological studies to provide material for testing a broad range of etiological hypotheses. One component of sample collection in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial involves shipment of blood in acid-citrate-dextrose anticoagulant to a central processing laboratory, where 10% DMSO is added, and whole blood aliquots are cryopreserved. A single technician is able to routinely process 5060 samples/day. Tests conducted to evaluate potential uses of cryopreserved whole blood showed successful EBV transformation (>90%, up to 20 months of storage). In addition, lymphocytes maintained good viability and stable T-cell:B-cell ratios, and T cells maintained the capacity to proliferate in response to solid phase anti-CD3/CD28 plus interleukin 2. Whole blood cryopreservation is a cost-effective approach to large-scale storage of viable cells in epidemiological studies.
This article has been cited by other articles:
![]() |
V. L. Stevens, A. V. Patel, H. S. Feigelson, C. Rodriguez, M. J. Thun, and E. E. Calle Cryopreservation of Whole Blood Samples Collected in the Field for a Large Epidemiologic Study Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2160 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Vaught Blood collection, shipment, processing, and storage. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1582 - 1584. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Vaught Blood: Collection, Shipment, Processing, and Storage Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 366 - 371. [Full Text] [PDF] |
||||
![]() |
J. P. Jakupciak, W. Wang, P. E. Barker, S. Srivastava, and D. H. Atha Analytical Validation of Telomerase Activity for Cancer Early Detection: TRAP/PCR-CE and hTERT mRNA Quantification Assay for High-Throughput Screening of Tumor Cells J. Mol. Diagn., August 1, 2004; 6(3): 157 - 165. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |